(Q37789774)

English

Use of additive solutions and pathogen inactivation treatment of platelet components in a regional blood center: impact on patient outcomes and component utilization during a 3-year period

scientific article published on 16 September 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

Use of additive solutions and pathogen inactivation treatment of platelet components in a regional blood center: impact on patient outcomes and component utilization during a 3-year period (English)

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

1 reference

based on heuristic

inferred from title

Jean-Pierre Cazenave

1

object named as

Jean-Pierre Cazenave

0 references

author name string

Jean-Pierre Cazenave

1

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

Hervé Isola

2

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

Chantal Waller

3

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

Isabelle Mendel

4

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

Daniel Kientz

5

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

Michel Laforêt

6

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

Jean-Pierre Raidot

7

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

Gérard Kandel

8

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

Marie-Louise Wiesel

9

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

Laurence Corash

10

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

publication date

16 September 2010

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

51

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

622-629

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

Methylene blue-photoinactivated plasma vs. fresh-frozen plasma as replacement fluid for plasma exchange in thrombotic thrombocytopenic purpura.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.02873.X

21 January 2018

Role of methylene blue-treated or fresh-frozen plasma in the response to plasma exchange in patients with thrombotic thrombocytopenic purpura.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.02873.X

21 January 2018

Hemovigilance network in France: organization and analysis of immediate transfusion incident reports from 1994 to 1998.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.02873.X

21 January 2018

In vitro evaluation of pooled buffy coat platelets treated with photochemical pathogen inactivation using amotosalen

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.02873.X

21 January 2018

Therapeutic efficacy and safety of photochemically treated apheresis platelets processed with an optimized integrated set.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.02873.X

21 January 2018

Leukocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusions

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.02873.X

21 January 2018

The threshold for prophylactic platelet transfusions in adults with acute myeloid leukemia. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.02873.X

21 January 2018

Transfusion of pooled buffy coat platelet components prepared with photochemical pathogen inactivation treatment: the euroSPRITE trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.02873.X

21 January 2018

Therapeutic efficacy and safety of platelets treated with a photochemical process for pathogen inactivation: the SPRINT Trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.02873.X

21 January 2018

An active haemovigilance programme characterizing the safety profile of 7437 platelet transfusions prepared with amotosalen photochemical treatment

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.02873.X

21 January 2018

A prospective observational cohort safety study of 5106 platelet transfusions with components prepared with photochemical pathogen inactivation treatment

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.02873.X

21 January 2018

Transfusion of platelet components prepared with photochemical pathogen inactivation treatment during a Chikungunya virus epidemic in Ile de La Réunion

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.02873.X

21 January 2018

Universal adoption of pathogen inactivation of platelet components: impact on platelet and red blood cell component use.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.02873.X

21 January 2018

Identifiers

10.1111/J.1537-2995.2010.02873.X

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

23 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37789774&oldid=2170075945"